Dogwood Therapeutics, Inc. (DWTX)
1.11
+0.07
(+6.73%)
USD |
NASDAQ |
Nov 06, 10:17
Dogwood Therapeutics Market Cap : 37.33M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 34.97M |
| November 04, 2026 | 34.64M |
| November 03, 2026 | 34.97M |
| November 02, 2026 | 41.03M |
| October 30, 2026 | 43.05M |
| October 29, 2026 | 41.36M |
| October 28, 2026 | 41.70M |
| October 27, 2026 | 39.01M |
| October 26, 2026 | 37.33M |
| October 23, 2026 | 37.67M |
| October 22, 2026 | 37.67M |
| October 21, 2026 | 39.35M |
| October 20, 2026 | 38.67M |
| October 19, 2026 | 40.69M |
| October 16, 2026 | 41.03M |
| October 15, 2026 | 42.04M |
| October 14, 2026 | 42.71M |
| October 13, 2026 | 43.72M |
| October 12, 2026 | 46.07M |
| October 09, 2026 | 47.08M |
| October 08, 2026 | 47.42M |
| October 07, 2026 | 48.09M |
| October 06, 2026 | 51.12M |
| October 05, 2026 | 51.12M |
| October 02, 2026 | 49.10M |
| Date | Value |
|---|---|
| October 01, 2026 | 48.09M |
| September 30, 2026 | 45.40M |
| September 29, 2026 | 45.40M |
| September 28, 2026 | 45.74M |
| September 25, 2026 | 45.74M |
| September 24, 2026 | 48.09M |
| September 23, 2026 | 50.78M |
| September 22, 2026 | 50.78M |
| September 21, 2026 | 53.81M |
| September 18, 2026 | 56.83M |
| September 17, 2026 | 57.84M |
| September 16, 2026 | 57.17M |
| September 15, 2026 | 58.18M |
| September 14, 2026 | 62.05M |
| September 11, 2026 | 65.24M |
| September 10, 2026 | 63.22M |
| September 09, 2026 | 65.24M |
| September 08, 2026 | 68.60M |
| September 04, 2026 | 77.01M |
| September 03, 2026 | 79.37M |
| September 02, 2026 | 83.40M |
| September 01, 2026 | 88.45M |
| August 31, 2026 | 86.76M |
| August 28, 2026 | 89.12M |
| August 27, 2026 | 78.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.599B |
| Alnylam Pharmaceuticals, Inc. | 21.22B |
| Anika Therapeutics, Inc. | 223.63M |
| Savara, Inc. | 949.97M |
| Vericel Corp. | 2.613B |
Market Cap Related Metrics
| Price to Book Value | 0.5460 |
| Price | 1.11 |
| Earnings Yield | -806.3% |